Prospective Study of Sinonasal and Skull-base Tumours Management

NCT ID: NCT05607888

Last Updated: 2024-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-01

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational prospective clinical study aims to describe the epidemiology, management and outcome of patients with sinonasal and skull-base pathology (tumours and diseases with malignant clinical characteristics) in a tertiary otorhinolaryngology referral centre. The main questions it aims to answer are:

* what is the caseload of patients with the included pathology in our centre
* what are the results of management of these cases
* what are the epidemiological characteristics of included patients
* what is the quality of life of included patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sinonasal tumours and tumours that involve the adjacent skull base are rare entities. However, their management necessitates a special knowledge of ENT areas and specifics of sinonasal anatomy and skull base. Due to the heterogeneity of pathological diagnoses of sinonasal and skull-base tumours, one of the main aims of this study is to provide epidemiological characteristics in our geographical area. Furthermore, to compare with other tertiary referral centres, we will analyse management results, which could improve the management of these diseases. Since the sinonasal area and skull base house several important neuroanatomical structures and senses, we aim to provide an analysis of the patient-reported quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nasal Neoplasm Nasal Neoplasm Benign Skull Base Neoplasms Skull Base Osteomyelitis Sinonasal Disorder Sinus Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* sinonasal and/or skull-base cancer
* sinonasal disease expanding through the skull-base
* the patient's written informed consent

Exclusion Criteria

* lateral skull-base disease primarily originating in the temporal bone and without central skull-base involvement
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Ljubljana, Faculty of Medicine

OTHER

Sponsor Role collaborator

University Medical Centre Ljubljana

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Domen Vozel, MD, PhD

Domen Vozel, MD, PhD, principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Domen Vozel, MD, PhD

Role: STUDY_DIRECTOR

University Medical Centre Ljubljana

Jure Urbančič, MD

Role: STUDY_DIRECTOR

University Medical Centre Ljubljana

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Medical Centre Ljubljana

Ljubljana, , Slovenia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Slovenia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Domen Vozel, MD, PhD

Role: CONTACT

+38641747865

Jure Urbančič, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Domen Vozel, MD, PhD

Role: primary

Jure Urbančič, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sinonasal tumours

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.